Cargando…
Nephroprotective action of glycosaminoglycans: why the pharmacological properties of sulodexide might be reconsidered
A relatively large body of evidence supports the notion that glomerular capillary wall and mesangial alterations in diabetic nephropathy involve biochemical alterations of glycoproteins in these structures. Evidence in experimental animals rendered diabetic reveals that the administration of heparin...
Autores principales: | Gaddi, Antonio V, Cicero, Arrigo FG, Gambaro, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108767/ https://www.ncbi.nlm.nih.gov/pubmed/21694935 |
Ejemplares similares
-
Sulodexide for Diabetic-Induced Disabilities: A Systematic Review and Meta-Analysis
por: Bignamini, Angelo A., et al.
Publicado: (2021) -
A new mechanism of action of sulodexide in diabetic nephropathy: inhibits heparanase-1 and prevents FGF-2-induced renal epithelial-mesenchymal transition
por: Masola, Valentina, et al.
Publicado: (2012) -
Preclinical and clinical evidence of nephro- and cardiovascular protective effects of glycosaminoglycans
por: Cicero, Arrigo F., et al.
Publicado: (2010) -
The renoprotective effects of sulodexide
por: Olde Engberink, Rik HG, et al.
Publicado: (2016) -
Sulodexide in IgA nephropathy
Publicado: (2013)